Interventional Study
a clinical trial in which a new drug or device is used to measure a specific outcome.
VX-NEN-801
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin.
Breve descripción
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin.
Patrocinador
Vertex
Interventional Study
a clinical trial in which a new drug or device is used to measure a specific outcome.
VX-NEN-801
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin.
Breve descripción
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin.
La prueba es para personas con
Chronic kidney disease not caused by diabetes, a history of proteinuria and no other identifiable cause of kidney disease.
Objetivo del estudio
This clinical research study is investigating how many individuals with chronic kidney disease (CKD) not caused by diabetes have a genetic form of the disease due to a variation in the apolipoprotein L1 (APOL1) gene.
¿Qué implica para el paciente?
Patient will be asked to provide a blood and saliva sample on the day of visit. There will only be one (1) visit for this study. Study participants will be contacted and informed of the genetic test results when they become available.